Home›Drug Pipeline› Bangga extracts show antibacterial, anti-inflammatory, antiviral, and antitumor activity in preclinical synthesis
Bangga extracts show antibacterial, anti-inflammatory, antiviral, and antitumor activity in preclinical synthesisExtracts of Aconitum tanguticum Show Potential for Several Conditions
Frontiers in MedicinePublished September 13, 2026DOI ↗Editorial oversight: Dr. Julia Lee, PhD · Oncology, Genomics & Drug Development
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret Bangga activity as preclinical only; clinical use is not supported.
This systematic review examines the biological activities of Aconitum tanguticum (Maxim.) Stapf., known as Bangga, across a range of conditions including infectious, inflammatory, liver, biliary, lung, and cardiovascular diseases. The authors synthesize evidence that extracts of Bangga demonstrate antibacterial, anti-inflammatory, antiviral, and antitumor properties.
The review covers conditions such as gastroenteritis, influenza, food poisoning, cholecystitis, hand-foot-mouth disease, asthma, osteoporosis, inflammatory bowel disease, cardiovascular diseases, and acute lung injury. However, no effect sizes, absolute numbers, p-values, or confidence intervals were reported for any outcome.
Safety data were not reported, including adverse events, serious adverse events, discontinuations, and tolerability. The authors acknowledge a need for further research to facilitate translation into clinical practice.
Practice relevance is described as potential for integration into modern healthcare for inflammatory bowel disease, cardiovascular diseases, and acute lung injury, but the review explicitly cautions against overstating clinical application and therapeutic potential. The evidence remains preclinical and does not support clinical use at this stage.
How this fits prior evidence
This review extends prior coverage of anti-infective strategies, such as quorum sensing inhibitors, by examining a plant-derived extract with reported antibacterial and antiviral properties. It also aligns with prior findings on influenza vaccine effectiveness and pregnancy-related influenza risks by including influenza among the conditions discussed, though no comparative effectiveness data are provided. Unlike prior coverage of opt-out nudges for vaccination or AI diagnostic accuracy, this review remains preclinical and does not report clinical outcomes or safety.
A systematic review looked at the biological activities of Aconitum tanguticum, also known as Bangga. The review focused on the properties of extracts from this plant to see if they could be useful for various health issues. The findings showed that these extracts possess antibacterial, antiviral, anti-inflammatory, and antitumor properties.
These properties suggest that the plant could potentially be useful in treating several conditions. These include inflammatory bowel disease, cardiovascular diseases, and acute lung injury. It may also have relevance for other conditions like asthma, lung diseases, and liver disorders.
It is important to note that this research is currently in the early stages. Because this is a systematic review of properties rather than a clinical trial on humans, the results are not yet ready to change how doctors treat patients. More research is needed to see if these findings can be safely and effectively used in medical practice.
What this means for you:
Aconitum tanguticum extracts show promising properties, but more research is needed before clinical use.
Common questions
What are the potential benefits of Aconitum tanguticum?
Extracts from Aconitum tanguticum, also known as Bangga, have shown antibacterial, anti-inflammatory, antiviral, and antitumor properties. These properties suggest it could potentially be useful for treating conditions like inflammatory bowel disease, cardiovascular diseases, and acute lung injury.
Can Aconitum tanguticum be used to treat lung or heart disease?
The review suggests that the plant's properties could potentially be integrated into modern healthcare for cardiovascular diseases and acute lung injury. However, more research is needed to confirm how it can be used in clinical practice.
Is Aconitum tanguticum ready to be used as a medical treatment?
No, it is not ready for clinical use yet. The current evidence shows potential biological activities, but the study notes that more research is required to translate these findings into actual medical treatments for patients.
Aconitum tanguticum (Maxim.) Stapf., commonly known as “Bangga” when used in combination with Aconitum naviculare (Brühl.) Stapf., is a traditional Tibetan medicine widely used in medicinal preparations. It is documented in the Si-Bu-Yi-Dian and Jing-Zhu-Ben-Cao and is mainly used to treat infectious and inflammatory conditions such as fever, liver and biliary disorders, lung diseases, gastroenteritis, influenza, and food poisoning. The primary bioactive ingredients of Bangga include diterpenoids, flavonoids, and phenolic acids. Additionally, extracts of Bangga have numerous beneficial biological activities, including antibacterial, anti-inflammatory, antiviral, and antitumor properties. The integration of traditional Tibetan medicinal formulas with modern pharmacological research can reveal new directions for clinical applications. For example, other formulas such as Ba-Wei-Zhang-Ya-Wan, An-Er-Ning-Ke-Li, and Er-Shi-Wu-Wei-Gui-Jiu-Wan have shown efficacy in treating cholecystitis, pediatric hand-foot-mouth disease and asthma, and osteoporosis, respectively. Previous phytochemical research has mainly focused on its alkaloids, flavonoids, phenolic acids, and volatile oils. Accordingly, this review presents a comprehensive overview of studies on the traditional uses, chemical composition, and modern pharmacological effects of Aconitum tanguticum (Maxim.) Stapf. This review systematically summarizes the multi-target pharmacological mechanisms of its alkaloids, flavonoids, and phenolic acids, highlights its therapeutic potential in treating inflammatory bowel disease, cardiovascular diseases, and acute lung injury, and provides a theoretical basis for the integration of this ethnic medicine into modern healthcare. Furthermore, it emphasizes the need for further research to facilitate its translation into clinical practice and advance its global recognition as a promising therapeutic agent.
